indocyanine green has been researched along with Hepatitis B Virus Infection in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (38.46) | 18.7374 |
1990's | 1 (7.69) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 4 (30.77) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Li, Y; Qian, P; Ren, L; Wang, H; Wang, X; Wang, Y; Wei, Y; Xiao, P; Zhang, H; Zhang, Y | 1 |
Bi, S; Chen, B; Chen, R; Nie, L; Ren, L; Shan, W; Ye, S; Zhang, Q; Zhao, J; Zhou, X | 1 |
Hsiao, JK; Huang, YY; Wu, MR | 1 |
Cao, W; Shan, J; Tang, K; Tian, F | 1 |
Chen, Y; Cheng, XP; Duan, ZP; Liu, YM; Meng, FK; Meng, QH; Meng, S; Xu, B; Yu, HW; Zhang, JY; Zhang, SB; Zhao, J; Zheng, SJ | 1 |
Chen, Y; Fan, ZP; Gao, Y; Liu, YR; Yang, W | 1 |
Juszczyk, J; Kaczmarek, Z; Klemczak, K; Kryska, A | 1 |
Kobayashi, N; Kuroda, H; Nambu, M; Namihisa, T | 1 |
Hirose, S; Imai, Y; Kinoshita, R; Miura, K; Nakagawa, T; Suzuki, S; Tanaka, S; Uchino, H | 1 |
Kuksenkov, ES; Saleev, GA; Sorinson, SN | 1 |
Huet, PM; Lelorier, J | 1 |
Kawata, A; Kondo, Y; Namieno, T; Sato, N; Uchino, J | 1 |
Ishikawa, H; Kakisaka, Y; Kashima, K; Mitsuyoshi, H; Nakajima, Y; Nakamura, H; Nakashima, T; Sumida, Y; Yodoi, J; Yoh, T | 1 |
13 other study(ies) available for indocyanine green and Hepatitis B Virus Infection
Article | Year |
---|---|
[Correlation of the CTD structural domain of hepatitis B virus core protein with the encapsulation effect of indocyanine green].
Topics: Animals; Hepatitis B; Hepatitis B Core Antigens; Indocyanine Green; Mice; Nanoparticles; Viral Core Proteins | 2022 |
Improved Stable Indocyanine Green (ICG)-Mediated Cancer Optotheranostics with Naturalized Hepatitis B Core Particles.
Topics: Hepatitis B; Humans; Indocyanine Green; Neoplasms; Photochemotherapy; Phototherapy | 2018 |
Role of Sodium Taurocholate Cotransporting Polypeptide as a New Reporter and Drug-Screening Platform: Implications for Preventing Hepatitis B Virus Infections.
Topics: Animals; Cell Line, Tumor; Cyclosporine; Cytoplasm; Female; Fluorescent Dyes; Genes, Reporter; HEK293 Cells; Hepatitis B; Hepatitis B virus; Hepatitis D; Hepatitis Delta Virus; Hepatocytes; Humans; Indocyanine Green; Liver; Mice; Mice, Inbred BALB C; Mice, Nude; Organic Anion Transporters, Sodium-Dependent; Symporters; Taurocholic Acid | 2020 |
[Assessment of the predictive value of the model for end-stage liver disease scoring system combined with the indocyanine green clearance test for short-term prognosis of acute-on-chronic hepatitis B liver failure].
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; End Stage Liver Disease; Female; Hepatitis B; Humans; Indocyanine Green; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Severity of Illness Index; Young Adult | 2014 |
Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
Topics: Aged; Area Under Curve; Biomarkers; Coloring Agents; Decision Support Techniques; Female; Hepatitis B; Humans; Indocyanine Green; Liver Cirrhosis; Liver Function Tests; Liver Transplantation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Reproducibility of Results; Risk Factors; ROC Curve; Sodium | 2016 |
[Clinical evaluation of liver storage function by indocyanine green retention test].
Topics: Adult; Aged; Female; Hepatitis B; Humans; Indocyanine Green; Liver; Liver Function Tests; Male; Middle Aged; Young Adult | 2010 |
[Evaluation of the study of the elimination of indocyanine green by long-term intravenous infusion in the diagnosis of liver damage].
Topics: Acute Disease; Adult; Brucellosis; Diagnosis, Differential; Female; Hepatitis; Hepatitis B; Hepatitis, Chronic; Humans; Indocyanine Green; Infusions, Parenteral; Male; Middle Aged; Psittacosis; Time Factors | 1982 |
Nine cases with marked retention of indocyanine green test and normal sulfobromophthalein test without abnormal liver histology: constitutional indocyanine green excretory defect.
Topics: Adenocarcinoma; Adult; Aged; Cholelithiasis; Diagnostic Errors; Duodenal Ulcer; Female; Hepatitis B; Humans; Hyperbilirubinemia; Indocyanine Green; Liver; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Sigmoid Neoplasms; Sulfobromophthalein | 1981 |
Indirect hyperbilirubinemia in HBV carriers.
Topics: Bilirubin; Carrier State; Hepatitis B; Hepatitis B Surface Antigens; Humans; Hyperbilirubinemia; Indocyanine Green; Nicotinic Acids; Sulfobromophthalein | 1980 |
[Indocyanine green chromodiagnostic test in acute viral hepatitis and other liver diseases].
Topics: Adult; Convalescence; Hepatitis A; Hepatitis B; Hepatitis, Viral, Human; Humans; Indocyanine Green; Jaundice; Liver Diseases; Liver Neoplasms; Middle Aged; Sulfobromophthalein | 1980 |
Effects of smoking and chronic hepatitis B on lidocaine and indocyanine green kinetics.
Topics: Administration, Oral; Adult; Biological Availability; Chronic Disease; Female; Hepatitis B; Humans; Indocyanine Green; Kinetics; Lidocaine; Liver; Liver Circulation; Liver Cirrhosis; Male; Metabolic Clearance Rate; Middle Aged; Smoking | 1980 |
Age-related, different clinicopathologic features of hepatocellular carcinoma patients.
Topics: Adolescent; Adult; Age Factors; Aged; alpha-Fetoproteins; Carcinoma, Hepatocellular; Carrier State; Child; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Indocyanine Green; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Neoplasm Staging | 1995 |
Thioredoxin levels in the sera of untreated viral hepatitis patients and those treated with glycyrrhizin or ursodeoxycholic acid.
Topics: Adult; Aged; Case-Control Studies; Female; Glycyrrhizic Acid; Hepatitis B; Hepatitis C; Humans; Indocyanine Green; Lipid Peroxides; Male; Middle Aged; Oxidative Stress; Thioredoxins; Ursodeoxycholic Acid | 2000 |